Richard Stanford
Overview
Explore the profile of Richard Stanford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirst C, Calingaert B, Stanford R, Castellsague J
J Asthma
. 2010 Jun;
47(4):439-46.
PMID: 20528600
Background: Current asthma guidelines recommend the use of long-acting beta-agonists (LABAs) in combination with inhaled corticosteroids (ICSs) for long-term control and prevention of symptoms in persistent asthma. Data on the...
2.
Garris C, Shah M, Dsouza A, Stanford R
Clin Drug Investig
. 2009 Jul;
29(8):515-26.
PMID: 19591513
Background And Objective: Intranasal corticosteroids are considered to be highly effective in patients with perennial or seasonal allergic rhinitis. Multiple intranasal corticosteroid products are available; however, an intranasal corticosteroid that...
3.
Meltzer E, Nathan R, Derebery J, Stang P, Campbell U, Yeh W, et al.
Allergy Asthma Proc
. 2009 Jun;
30(3):244-54.
PMID: 19549425
Rhinitis is a common chronic condition that has been shown in observational and interventional studies to have a substantial impact on the sufferer. This study was performed to describe the...
4.
Nathan R, Meltzer E, Derebery J, Campbell U, Stang P, Corrao M, et al.
Allergy Asthma Proc
. 2009 Jan;
29(6):600-8.
PMID: 19173786
Although the annual prevalence of physician-diagnosed hay fever has been previously reported, the prevalence of allergic rhinitis symptoms in the United States is uncertain. The purpose of this study was...
5.
Earnshaw S, Wilson M, Dalal A, Chambers M, Jhingran P, Stanford R, et al.
Respir Med
. 2008 Nov;
103(1):12-21.
PMID: 19010652
Objective: We examine the lifetime cost-effectiveness of treatment with fluticasone propionate/salmeterol (500/50 microg) compared with no maintenance treatment in COPD in the US. Methods: A decision-analytic model was developed to...
6.
Dalal A, Stanford R, Henry H, Borah B
Ann Allergy Asthma Immunol
. 2008 Aug;
101(1):23-9.
PMID: 18681080
Background: Little is known about the specific cost effect of rhinitis on third-party payers. No recently reported studies have examined the economic burden of rhinitis in managed care. Furthermore, the...
7.
Derebery J, Meltzer E, Nathan R, Stang P, Campbell U, Corrao M, et al.
Otolaryngol Head Neck Surg
. 2008 Jul;
139(2):198-205.
PMID: 18656715
Objective: To assess the burden of nasal symptoms in the United States (U.S.) and the comorbid conditions associated with nasal symptoms. Subjects And Methods: A self-administered screening questionnaire and follow-up...
8.
Delea T, Stanford R, Hagiwara M, Edelsberg J, Oster G
Int J Cardiol
. 2005 Feb;
99(1):117-24.
PMID: 15721509
Background: The Carvedilol or Metoprolol European Trial (COMET) demonstrated improved survival with carvedilol vs. metoprolol tartrate in patients with heart failure. The benefits of carvedilol in typical clinical practice in...
9.
OConnor R, Stanford R, Crim C, Yancey S, Edwards L, Rickard K, et al.
Ann Allergy Asthma Immunol
. 2004 Dec;
93(6):581-8.
PMID: 15609769
Background: Inhaled corticosteroids are the most effective class of anti-inflammatory agents and are recommended for patients with persistent asthma. Objective: To compare the effectiveness of (1) fluticasone propionate, 100 microg,...